OTCMKTS:EMHTF Emerald Health Therapeutics (EMHTF) Stock Price, News & Analysis $0.04 +0.01 (+55.17%) As of 11/11/2022 Add Compare Share Share Stock Analysis Stock Analysis About Emerald Health Therapeutics Stock (OTCMKTS:EMHTF) Get EMHTF alerts:Sign Up Key Stats Today's Range$0.03▼$0.0450-Day Range$0.04▼$0.0452-Week Range$0.02▼$0.09Volume1.05 million shsAverage Volume116,962 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Emerald Health Therapeutics is a Canadian licensed producer of cannabis and cannabinoid-derived products, headquartered in Vancouver, British Columbia. The company cultivates and processes cannabis biomass in its indoor and greenhouse facilities, with a focus on producing a range of flower, oils and concentrates for medical and adult-use markets. Emerald Health operates under Health Canada’s regulations and holds licences that permit the cultivation, processing and sale of cannabis in dried and oil formats. Alongside its cultivation activities, Emerald Health has developed proprietary extraction technologies to produce high-purity cannabinoid isolates and broad-spectrum extracts. The company’s product portfolio includes ready-to-use oils, terpene-rich distillates and formulations designed for ease of dosing. Emerald Health supplies its products to provincial distributors across Canada and is exploring partnerships to expand its presence in international medical markets. Founded by a team of industry professionals, Emerald Health Therapeutics has pursued vertical integration to control quality and yield across its operations. The company has invested in research and development initiatives aimed at optimizing cultivation protocols and advancing novel cannabinoid formulations. While Emerald Health primarily serves the Canadian market, its management has signaled interest in leveraging export opportunities where regulatory frameworks permit.AI Generated. May Contain Errors. Read More Receive EMHTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EMHTF Stock News HeadlinesEmerald Growth A HSPGXSeptember 15, 2024 | morningstar.comMViking Therapeutics, Inc. (VKTX)August 21, 2024 | finance.yahoo.comThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.August 26 at 1:00 AM | Chaikin Analytics (Ad)Emerald D. RobinsonOctober 6, 2023 | health.usnews.comEmerald Health Pharmaceuticals Receives Safety Review Committee Approval to Proceed to Final Cohorts of EHP-101 Phase 2a Systemic Sclerosis TrialJanuary 12, 2023 | finance.yahoo.comIIROC Trading Halt - EMHNovember 9, 2022 | finance.yahoo.comEmerald Health Therapeutics and Skye Bioscience Announce Intended Closing Date of Plan of ArrangementNovember 7, 2022 | finance.yahoo.comEmerald Health Therapeutics Q2 GAAP EPS of -C$0.01, revenue of C$1.28MSeptember 2, 2022 | seekingalpha.comSee More Headlines EMHTF Stock Analysis - Frequently Asked Questions How have EMHTF shares performed this year? Emerald Health Therapeutics' stock was trading at $0.0405 on January 1st, 2026. Since then, EMHTF shares have increased by 0.0% and is now trading at $0.0405. How do I buy shares of Emerald Health Therapeutics? Shares of EMHTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:EMHTF CIK1768225 Webwww.emerald.care Phone(800) 757-3536FaxN/AEmployees110Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:EMHTF) was last updated on 8/26/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredNear retirement? Buy this stockOn August 9, the Wall Street Journal profiled a unique AI strategy used by three companies. Whitney Tilson of ...Stansberry Research | SponsoredFree Stock Pick: The Company First in Line for America’s New Super FuelThe U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...Banyan Hill Publishing | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Health Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emerald Health Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.